Voya Financial (NYSE:VOYA) is breaking out to new highs as it continues to gather assets due to its diversified, unique offerings. In recent quarters, the company has attracted impressive feeable asset growth as it adapts to the market's needs, while offering benchmark-beating results. Its share
Massachusetts Financial Services Co. MA increased its position in shares of HMS Holdings (NASDAQ:HMSY) by 40.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,007,174 shares of the business services provid
&l;p&g;&l;img class=&q;size-full wp-image-1343&q; src=&q;http://blogs-images.forbes.com/mikescott/files/2018/01/CSP.jpg?width=960&q; alt=&q;&q; data-height=&q;445&q; data-width=&q;1000&q;&g; The Masdar-backed Gemasolar concentrated solar power plant in Spain. A similar plant will be open in the UAE in the next few years.
Even in the Middle East, home to some of the world&a;rsquo;s largest....More>>>
Interest rates at FDIC-insured banks remain at an all-time low. I’ve tracked rates for more than a decade on sites such as Magnify Money and Consumerism Commentary. Back in the day rates of 5.00% or more were common. It may take us years to get back to those levels.
Automated teller machines (ATM) are seen inside a Citigroup Inc. bank branch in Chicago, Illinois, U.S., on Saturday,....More>>>
Something unexpected just happened… A tiny piece of earth was lobbed into a very deep regulatory black hole.
The Senior Judge of the U.S. District Court for the Western District of Washington, Judge Barbara Jacobs Rothstein, ruled last week that the accounting giant PricewaterhouseCoopers was liable for failing to uncover a multibillion-dollar fraud....More>>>
The technicians love the biotech sector–and the iShares Nasdaq Biotechnology ETF (IBB)–today. Earlier today, we discussed Cornerstone Macro’s Carter Worth, who predicts big upside for the health-care sector generally, and some biotech stocks specifically, Regeneron Pharmaceuticals (REGN) and Amgen (AMGN) among them. Now, the folks at Bespoke Investment Group have published their....More>>>
Paying generous dividends is a classic way for companies to attract stable investors. But just because a company can afford to pay big dividends doesn’t mean that it ever will. Let’s take a look at three companies that have low payout ratios but still pay paltry dividends that are lower than the S&P 500’s yield of 2%.
Small cap diabetes stocks Oramed Pharmaceuticals, Inc (NASDAQ: ORMP), Senseonics Holdings (NYSEMKT: SENS) and Cell MedX Corp (OTCQB: CMXC) might not immediately come to mind when you think of the disease. However, theres plenty of room in the market place for players of all sizes. Just consider some quick statistics about diabetes compiled by Cell MedX Corp:
McDonald’s investors (NYSE:MCD) are celebrating a Trump victory that will usher in an administration far more friendly to businesses. A Republican government may do its part in avoiding things like the golden arch being liable for independent contractor violations or in voiding the penalties faced by employers under the Obamacare mandates.....More>>>
Any time a growth stock like Amazon (NSDQ:AMZN) comes under pressure, value investors come out in droves citing the company’s ridiculously high earnings multiple as reason enough to stay clear of the stock. Growth investors and value investors are two entirely different breeds. One looks for deeply discounted fundamentally strong companies whereas growth investors concentrate a lot on growth....More>>>
Come on Musk. Shame on you Tesla (TSLA) CEO Elon Musk for trashing The Economist on Twitter - it was a very Trumpian move. Said Musk on Twitter last night, "The Economist used to be boring, but smart with a wicked dry wit. Now it's just boring (sigh). Tesla will be profitable & cash flow+ in Q3